Exponent (EXPO) Releases Earnings Results, Beats Expectations By $0.05 EPS

Exponent (EXPO) reported quarterly earnings results on Wednesday, Apr-20-2016. The company said it had a profit of $0.40 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.05. Analysts had a consensus of $0.35. The company posted revenue of $79.00 million in the period, compared to analysts expectations of $75.89 million. The company’s revenue was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.75 EPS.

Exponent opened for trading at $49.95 and hit $50.3493 on the upside on Monday, eventually ending the session at $50.2, with a gain of 0.20% or 0.1 points. The heightened volatility saw the trading volume jump to 68,221 shares. Company has a market cap of $1,291 M.

In a different news, on Feb 24, 2016, Robert D Caligiuri (Group Vice President) sold 5,000 shares at $47.50 per share price. According to the SEC, on Nov 12, 2015, Richard L Jr Schlenker (EVP & Chief Financial Officer) sold 20,000 shares at $51.45 per share price. On Oct 28, 2015, Paul Boehm (Group Vice President) sold 10,000 shares at $52.33 per share price, according to the Form-4 filing with the securities and exchange commission.

Exponent Inc. is a science and engineering consulting firm that provides solutions to complex problems. The Company serves clients in automotive aviation chemical construction consumer products energy Government health insurance manufacturing and technology among others. It provides engineering and scientific consulting services to clients around the world. It operates around 22 practices and centers in two operating segments: Engineering and Other Scientific and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics biomedical engineering buildings and structures construction consulting electrical engineering and computer science engineering management consulting thermal sciences and vehicle analysis services among others. Its Environmental and Health segment includes chemical regulation and food safety ecological and biological sciences environmental and earth sciences and mechanistic biology services among others.


Leave a Reply

Exponent - Is it time to Sell?

Top Brokerage Firms are advising their investors on Exponent. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.